- Home
- UWMC vs AORT Comparison
UWMC vs AORT Comparison
Compare UWMC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UWMC
- AORT
- Stock Information
- Founded
- UWMC 1986
- AORT 1984
- Country
- UWMC United States
- AORT United States
- Employees
- UWMC N/A
- AORT N/A
- Industry
- UWMC Finance: Consumer Services
- AORT Medical/Dental Instruments
- Sector
- UWMC Finance
- AORT Health Care
- Exchange
- UWMC Nasdaq
- AORT Nasdaq
- Market Cap
- UWMC 825.8M
- AORT 1.4B
- IPO Year
- UWMC N/A
- AORT 1993
- Fundamental
- Price
- UWMC $4.19
- AORT $30.39
- Analyst Decision
- UWMC Hold
- AORT Strong Buy
- Analyst Count
- UWMC 8
- AORT 5
- Target Price
- UWMC $6.18
- AORT $32.40
- AVG Volume (30 Days)
- UWMC 7.1M
- AORT 362.3K
- Earning Date
- UWMC 08-05-2025
- AORT 08-07-2025
- Dividend Yield
- UWMC 9.45%
- AORT N/A
- EPS Growth
- UWMC N/A
- AORT N/A
- EPS
- UWMC N/A
- AORT N/A
- Revenue
- UWMC $2,486,541,000.00
- AORT $390,084,000.00
- Revenue This Year
- UWMC $18.64
- AORT $12.20
- Revenue Next Year
- UWMC $14.78
- AORT $10.63
- P/E Ratio
- UWMC N/A
- AORT N/A
- Revenue Growth
- UWMC 10.39
- AORT 5.94
- 52 Week Low
- UWMC $3.80
- AORT $21.97
- 52 Week High
- UWMC $9.74
- AORT $32.94
- Technical
- Relative Strength Index (RSI)
- UWMC 49.49
- AORT 52.73
- Support Level
- UWMC $4.09
- AORT $30.70
- Resistance Level
- UWMC $4.29
- AORT $32.00
- Average True Range (ATR)
- UWMC 0.15
- AORT 0.81
- MACD
- UWMC 0.01
- AORT -0.13
- Stochastic Oscillator
- UWMC 48.81
- AORT 27.43
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.